In clearance studies, we analyzed the effect of Ca }+ entry blockade with nitrendipine treatment (20 mg b.i.d. for 4 days) and of converting enzyme inhibition with enalapril treatment (20 mg b.i.d. for 4 days) on renal response to atrial natriuretic factor (ANF) (25 fig bolus followed by an infusion of 0.03 /tg/kg/min for 90 minutes) in six healthy volunteers who were taking 300 mmol sodium daily. In a control study ANF was administered without Ca 2+ entry blockade or converting enzyme inhibition. Natriuresis rose from 239±38 to 605±137 /imol/min in the control study (p<0.05), from 330±53 to 943±152 /unol/min with Ca 2+ entry blockade (p<0.05), and from 236±22 to 344±39 /unol/min with converting enzyme inhibition (NS). ANF induced a rise in mairinial free water clearance, inulin clearance, and in the excretion of multiple electrolytes except potassium. Fractional lithium reabsorption fell. In general, these effects were stronger during Ca 2+ entry blockade and blunted during converting enzyme inhibition. p-Aminohippurate clearance tended to decrease during the control study (NS), remained constant during Ca 2+ entry blockade, and decreased significantly when ANF was infused during converting enzyme inhibition (p<0.05 vs. control and vs. Ca 2+ entry blockade study). Blood pressure was lowered by Ca 2+ entry blockade and, to a somewhat greater extent, by converting enzyme inhibition, but ANF administration induced no additional fall except for a short-term drop during Ca I+ entry blockade. From these data we conclude that, in healthy humans, the effects of ANF on natriuresis and renal sodium handling are enhanced by Ca 2+ entry blockade and blunted by converting enzyme inhibition. These effects might be explained by amplification of (preglomerular?) ANF-induced vasodilation during Ca 2+ entry blockade and amplification of (postglomerular?) ANF-induced vasoconstriction during converting enzyme inhibition. {Hypertension 1989;13:173-180) I n isolated perfused rat kidneys Ca 2+ entry blockade with verapamil was reported to inhibit the hemodynamic and natriuretic effect of atrial extract.1 By contrast, it was recently shown that nifedipine, although preventing the renal hemodynamic effect, potentiated the natriuretic effect of atrial natriuretic factor (ANF) in anesthetized rabbits.2 This study 2 could not confirm inhibition of ANF-natriuresis, but it was considered that anes- thesia and subsequent decreased renal nerve activity might have caused this new finding. Data in conscious animals or in humans are not available. Since Ca 2+ entry blockade interferes with the action of neurohumoral mechanisms such as renal sympathetic nerve activity and the renin-angiotensin system, 3 one way in which Ca 2+ entry blockade could influence the effect of ANF is by attenuating the effect of endogenous angiotensin II on the kidney. It was found by others 4 and by us 5 that angiotensin I converting enzyme inhibition blunts the natriuretic effect of ANF in humans. Although the mechanism of this interaction is not clear, it can be hypo...